Fintech PR
Anna Xu at SuperReturn 2023: HIKE Capital Invests in Visionary Founders to Pioneer Future Innovation
SINGAPORE, Sept. 25, 2023 /PRNewswire/ — Challenges in the global macroeconomic and political climate have not deterred HIKE Capital, a leading founders’ fund in China, from continuing to invest in innovative Chinese companies with the potential to shape the future.
“We believe that Chinese entrepreneurs have the resilience to weather these cycles and develop top-notch technologies and products to shake up the world in the next digital wave,” said Anna Xu, founder of HIKE Capital, at SuperReturn 2023 in Singapore.
China’s certainties in uncertain times
China has transitioned from its position as the world’s factory to become a global hub for product design and R&D, a remarkable fact that can be attributed in large part to China’s talent dividend.
China’s possession of the world’s largest pool of scientists and engineers, along with a growing number of college graduates, grants the country a significant competitive advantage in the digital economy.
Having developed the world’s most comprehensive industry system and a highly developed supply chain, China has established a commanding position in the new energy sector, especially in the electric vehicle business.
HIKE Capital has invested in multiple renowned EV companies, including prominent startup LiAuto (2017), and Megatronix (2019), an autonomous driving frontrunner that has achieved revenue growth of over 400% in the past two years.
Looking ahead to the next decade, “we can expect groundbreaking innovations in autonomous driving and smart cockpit technology to revolutionize the way we travel,” Anna said.
Innovation drives growth
China’s rapidly expanding digital economy has consistently outpaced GDP growth for 11 consecutive years, reaching 50.2 trillion yuan in 2022.
The industrial Internet has played a pivotal role in accelerating the digital transformation of manufacturing enterprises, empowering them to introduce groundbreaking products and experiences.
A prominent example is the rising athleisure brand Halara, another HIKE Capital portfolio company. Through smart factory technology, end-to-end digital circulation, and lean management, Halara has reduced its inventory turnover to just 35 days, outperforming its main competitor Lululemon, whose turnover stands at 110 days.
Another notable example is the new generation insurance broker Yuanbao. The company excels in customer acquisition, quality control of traffic pools, and cost-risk modeling achieved through its AI-powered matching technology. In less than a year, Yuanbao has already accumulated millions of paying users representing 90% regional coverage across China.
Partnership to drive digital transformation
As a Founders Fund, HIKE Capital’s core strategy prioritizes the continual exploration of world-class startups and strategic investments, particularly during technological waves.
Anna emphasized that the fund prioritizes partnerships with top entrepreneurs who possess unwavering faith in the power of technology and are committed to driving digital transformation.
“This approach enables us to transcend market cycles and stay at the forefront of innovation.”
Leveraging extensive experience and a mature methodology, HIKE Capital stands ready to assist more enterprises to achieve long-term success.
HIKE – Founders Fund
Founded in 2015, HIKE is a prominent technology venture capital firm in China co-founded by Mark Yang, the founder of CARS Group and Ganji.com, and Anna Xu, the founder of NetEase news app.
HIKE Capital is dedicated to supporting entrepreneurs and driving paradigm shifts in the early stages of their businesses.
With a team of experienced venture partners, HIKE Capital helps founders overcome growth barriers and connect with essential resources.
The firm manages both USD and RMB Funds, focusing on investments in transportation/new energy, digitalization of the supply chain, and tech-empowered industries.
HIKE Capital has a successful track record of investing in unicorn companies such as Li Auto (NASDAQ:LI, HKEX:2015), RELX (NYSE:RLX), CARS Group, Megatronix, Orienspace, Halara, Yuanbao Insurance, FlashEx, Spark Group, Fenbi (HKEX:2469), Yuanfudao, OnQuality, Xbiome, Artivila, etc.
Photo – https://mma.prnewswire.com/media/2219624/Anna_xu.jpg
View original content:https://www.prnewswire.co.uk/news-releases/anna-xu-at-superreturn-2023-hike-capital-invests-in-visionary-founders-to-pioneer-future-innovation-301937228.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
https://news.cision.com/eqt/i/eqt-ab-group,c3285895 |
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News5 days ago
BRI takes top spot in Indonesia and ranks 15th in the 2024 Fortune Southeast Asia 500, Further Cementing its Industry Prominence
-
Latest News4 days ago
Network Security Market Set to Reach $58.42 Billion by 2031 Due to Emerging Threats | SkyQuest Technology
-
Latest News6 days ago
VeriPark and FICO Announce Strategic Partnership to Transform Financial Services
-
Latest News4 days ago
Sunarso Wins Best CEO as BRI Takes Home 11 Awards at FinanceAsia Awards 2024
-
Latest News6 days ago
Falcon Investment Management Unlocks Ultra-Exclusive Hedge Fund Strategy for Family Offices
-
Latest News4 days ago
Jumio Study: Deepfakes, Fraud Fears Drive Demand for Stronger Bank Security
-
Latest News4 days ago
Frost Bank in Texas taps Finzly for instant payments
-
Latest News4 days ago
Global fintech revenue rose 14% in last two years: Report